[Presentation] VIVA 2025
- 泉美 福岡
- Oct 29
- 1 min read
Updated: Oct 29
Prof. Terumitsu Hasebe, Director of Global Vascular Co.,Ltd., will give a presentation at VIVA 2025 (Vascular InterVentional Advances), an international conference to be held in Las Vegas from November 2-5, 2025 (Pacific Time).
Prof. Hasebe will present the latest updates on the BioStealth™ Hybrid Drug-Eluting Stent (DES) and its ongoing pivotal clinical trial in the following session.
Presentation Information
Session Title: World Insights
Date & Time: Monday, November 3, 2025, 11:15–11:22 (Pacific Time, U.S.)
Venue: Wynn Las Vegas | InnoSphere
Presentation Title: BioStealth™ Hybrid DES Delivers Superior Patency and Rapid Healing in BTK Arteries: Pivotal Clinical Trial Underway
About VIVA * based on information from the official VIVA Foundation website
VIVA (Vascular InterVentional Advances) is one of the world’s leading international conferences focusing on endovascular and peripheral vascular interventions.
The event brings together vascular specialists, researchers, and industry professionals from around the globe to share the latest advances in technology, clinical research, and treatment strategies.
Event Overview
Conference: VIVA 2025 (Vascular InterVentional Advances)
Dates: November 2-5, 2025 (Pacific Time)
Venue: Wynn Las Vegas, Las Vegas, Nevada, U.S.
Organizer: VIVA Foundation